Tuesday, January 11, 2011

The CHAMPION Penny Stock Viropro Inc.(VPRO.PK)

The CHAMPION Penny Stock for Wednesday, January 05 is…

Viropro Inc.(VPRO.PK)
  • Last Trade: $0.14
  • Price changed: $0.14
  • Percentage Gain: +2,700%
  • Last Close: $0.01
  • Volume: 62,767,688
  • Dollar Volume: $8,787,476
Congrats to top stock pickers: Frank’s Penny Stocks, Friedman Report.

You are the King of the Stock Pickers today!

About Penny Stock Rumble: http://www.pennystockrumble.com/

What is the Penny Stock Rumble and how will it turn your trading around?

This FREE stock investment tool allows you to view all of your favorite penny stock pickers in one place.
Are you tired of getting hundreds of emails from all the penny stock pickers every single morning? Who has time to read them all, right?

With our Rumble Investment Tool, you can log into one convenient location and view all the day’s picks by your favorite penny stock pickers, along with market data (15 minute delayed).

If you trade in small cap or micro cap stocks, you need this tool. It is absolutely FREE and will give you that edge in the small cap trading arena you have been looking for.

The people making money trading penny stocks are the ones that are doing the research and figuring out which stock is hot and which penny stock is not.

It takes an incredible amount of work, but the rewards are huge!

Penny Stock Rumble allows you to check on all the penny stocks that are being promoted for that day. The layout includes all the market data streamed in from Yahoo Finance, so you can quickly check and see who is the top penny stock of the day and who is the dog.

It’s completely FREE and will help you get the edge back in your trading strategy.

About Viropro Inc.(VPRO.PK)

Viropro, Inc., a development stage company, operates in the pharmaceutical sector specializing in the sale of technological transfers for biopharmaceutical generic drugs in emerging markets in South America, northern Africa, and Asia. The company focuses on developing and out-licensing manufacturing processes for biogenerics already in the public domain as soon as patent protection expires for various biopharmaceuticals. It also has licenses to patented technologies related to the production of therapeutic proteins, such as alpha interferon, Interleukin 2, erythropoietin, and human growth factors, including rHuG-CSF and rHuGM-CSF. Viropro, Inc. has a strategic alliance with Biotechnology Research Institute of the National Research Council (Canada) to access equipment and facilities for bio-process innovation and purification process development. It also has a partnership with Intas Biopharmaceuticals Ltd. for the development and production of a therapeutic protein. The company is based in Montreal, Canada.

No comments:

Post a Comment